ABT vs NHI · P/E 25, rev $44.33B vs P/E 22, rev $54.4M
Abbott Laboratories (ABT) versus National Health Investors Inc (NHI) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
National Health Investors Inc (NHI) is a reit - healthcare facilities company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported NHI revenue for 2024-12-31 was $54.4M. Net income was $136.6M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. NHI currently screens at market cap $3.31B and trailing P/E 22.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. NHI currently screens at market cap $3.31B and trailing P/E 22.4.
Not investment advice. Open the ABT and NHI stock pages for the full models.
Not investment advice.